Dioscin protects against diabetic nephropathy by inhibiting renal inflammation through TLR4/NF- κB pathway in mice.

In conclusion, our study highlights the potential of dioscin as a novel approach to treat DN in diabetic patients.
PMID: 32359778 [PubMed - as supplied by publisher]

Source: Immunobiology - April 18, 2020 Category: Allergy & Immunology Authors: Cai S, Chen J, Li Y Tags: Immunobiology Source Type: research